This is in agreement with previous findings, since NFkB (complex) is part of the NFkB (family) with known roles in expression, apoptosis, proliferation, cell death, differentiation, etc. in various cancers, including liver cancer[24], abdominal, epithelial cancer, inflammation, diabetes[25], etc. The microRNAs miR-122, together with miR-133-a, miR-134-a and miR-24, conveniently detectable also in serum and plasma, have recently been reported as biomarkers for hepatic inflammation, contributing to NASH development[26, 27]. Here, NFKB1 is linked to liver cancer.